XOM trades against a final fair-value range of $113.02-$174.69, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $113, high $175, with mid-point at $139.
Englische Quelle wird angezeigt, während wir übersetzen
Dieser Bericht wurde noch nicht übersetzt. Aktualisieren Sie in ein paar Minuten, sobald die Übersetzungswarteschlange aufgeholt hat.
§1 Zusammenfassung
Composite fair value $139 with high case $175.
Implied downside of 3.6% to fair value.
Moat 6.5/10 · confidence 81/100 · Cyclical.
Trades close to fair value, so the margin of safety is limited either way.
Fair value
$139
Margin of safety
-3.7%
Confidence
81/100
Moat
6.5/10
Educational analysis only — not financial advice. Always do your own due diligence.
$144.64Price
Low $113.02
Mid $139.45
High $174.69
XOM trades against a final fair-value range of $113.02-$174.69, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
Scale and Cost Advantage
Premier integrated upstream and downstream operations provide structural cost advantages and margin capture across the entire value chain.
Asset Quality
Highly advantaged upstream positioning, particularly in the Permian Basin and Guyana, secures long-duration, low-breakeven production.
Bull thesis
Hold rating driven by limited upside to our $139.45 fair value estimate and high cycle timing uncertainty.
A sustained structural decline in crude oil prices below $50/bbl due to chronic oversupply and weakening demand, rendering marginal upstream assets economically unviable.
FV impact
Downside to $81.71 (5.8% discount rate, 1.0% terminal growth)
Trigger
2-3 Years
Stranded Asset Realization
· Medium
Aggressive global environmental regulations and carbon pricing mechanisms force the premature write-down of significant long-duration upstream and downstream reserves.
FV impact
Downside below $113.02 floor
Trigger
5-7 Years
Capital Misallocation Deflation
· Medium
The current $25.9B peak capital expenditure cycle fails to generate requisite returns, structurally depressing ROIC and forcing a persistent discount to net asset value.
FV impact
Downside to $103.04
Trigger
3-5 Years
Frühwarnsignale zur Überwachung
Kennzahl
Aktuell
Auslöseschwelle
Operating margins compress below the 11.57% historical mid-cycle median.
Monitor
Deterioration versus the report thesis
Capital expenditures systematically exceed targeted peak levels without revenue proportionality.
Monitor
Deterioration versus the report thesis
Operating cash flow to net income ratio falls below 1.2x, signaling earnings quality degradation.
Monitor
Deterioration versus the report thesis
Significant downward revisions in upstream reserve life or realization estimates.
Monitor
Deterioration versus the report thesis
Failure to maintain a 14x terminal multiple due to shifting institutional ESG mandates.
Monitor
Deterioration versus the report thesis
§3 Finanzielle Historie
Gewinn- und Verlustrechnung — letzte sechs Perioden
XOM (XOM)'s revenue growth is reported year-over-year across the most recent five fiscal years, with the deceleration or acceleration curve called out in the numbers-analysis subsection of the parent financials tab.
The deceleration curve is calibrated by archetype: hyper-growth names get a 5-10 percentage-point-per-year glide path, mature compounders converge to GDP-plus-inflation. Visibility-adjusted deceleration is documented in the assumption ledger.
Where the company reports segments, the segment composition is included in the financials section. The competitive-moat tab covers the qualitative drivers (pricing power, switching costs, distribution).
The parent financials tab carries five years of standardized revenue history. For the longer-term trend, the report's appendix logs data provenance and the source dataset identifier.
FAQ
XOM — frequently asked questions
Based on our latest analysis, XOM trades close to fair value. The current price is $145 versus a composite fair-value midpoint of $139 (range $113–$175), which implies roughly 3.6% downside to the midpoint.
Our composite fair-value range for XOM is $113–$175, with a midpoint of $139. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for XOM's archetype.
Our current rating for XOM is Hold with a confidence score of 81/100. XOM is rated Hold at $144.64 versus the reconciled fair value midpoint of $139.45, implying -3.59% upside/downside. Confidence is separately disclosed at 81/100. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for XOM are: Commodity Price Collapse; Stranded Asset Realization; Capital Misallocation Deflation. The single biggest risk is A 16% discount to internal valuation cross-checks ($166.27) is warranted due to assumed mean-reversion of commodity-driven margins.
Our current rating for XOM is Hold, issued with a confidence score of 81/100 and a moat score of 6.5/10. The rating reflects the composite fair-value range ($113–$175) versus the current price of $145.
XOM is classified as a cyclical stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for XOM.
